HHS, NIH launch next-generation universal vaccine platform for pandemic-prone viruses
View all comments(0)
May 1 (Reuters) - NIH :
NIH: HHS, NIH LAUNCH NEXT-GENERATION UNIVERSAL VACCINE PLATFORM FOR PANDEMIC-PRONE VIRUSES
NIH: CLINICAL TRIALS FOR UNIVERSAL INFLUENZA VACCINES ARE SCHEDULED TO BEGIN IN 2026
NIH: INTRANASAL BPL-1357 FLU VACCINE, CURRENTLY IN ADVANCED TRIALS, IS ALSO ON TRACK FOR FDA REVIEW BY 2029
Source text: [ID:]
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.